NCT05171114View on ClinicalTrials.gov

Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 28, 2021

Primary Completion Date

April 22, 2022

Study Completion Date

April 22, 2022

Conditions
Scleroderma, Systemic
Interventions
DIAGNOSTIC_TEST

Measurement of joint amplitudes

Measurement of joint amplitudes by goniometry of the MCP, IPP, IPD for 2, 3, 4 and 5th radii, 1st commissure spacing and Kapandji score for the thumb

Trial Locations (1)

87042

CHU de Limoges, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT05171114 - Scleroderma: Functional Disability Between the Dominant and Contralateral Hand. | Biotech Hunter | Biotech Hunter